Screener
Immix Biopharma, Inc. IMMX Q2 2026 earnings
Reported August 7, 2026 · Before market open
EPS-$0.18Miss by $0.01
EPS estimate-$0.17
Next report
Nov 6, 2026 (in 2 months)EPS estimate-$0.18
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Immix Biopharma, Inc. report Q2 2026 earnings?
- Immix Biopharma, Inc. (IMMX) reported Q2 2026 earnings on August 7, 2026 before market open.
- What were Immix Biopharma, Inc.'s Q2 2026 revenue and EPS?
- Immix Biopharma, Inc. reported eps of $-0.18 for Q2 2026.
- Did Immix Biopharma, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.17 by $0.01.
- How did Immix Biopharma, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 18.2% from $-0.22.
- Where can I find Immix Biopharma, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-036643) directly on SEC EDGAR. The filing index links above go to sec.gov.
